The effect of norfloxacin (NFLX), a new quinolone agent, was compared with that of pipemidic acid (PPA) on infectious enteritis (bacillary dysentery, Campylobacter enteritis and enteropathogenic E. coli enteritis etc.) by a double-blind method.
NFLX was administrated orally in a dose of 600mg/day, and PPA was administrated orally, 2, 000mg/day.
The duration of the treatment was five days.
Of 227 cases studied, 68 cases were excluded from analysis of effectiveness.
The effectiveness was evaluated in 159 cases; 80 reveived NFLX and 79 reveived PPA.
There was no statistical significance beteeen NFLX group and PPA group in terms of the background characteristics and MIC distribution for each drug.
The results obtained were as follow:
1. NFLX group was as same as PPA group in clinical effect judged by docters in charge.
There was no significnat difference between both groups in defeverscence, disappearance of blood stool, decrease in number of defecation and improvement of stool character.
2. In bacillary dysentery, the bacteriological effect of NFLX (100%) was superior to that of PPA (88.9%).
Days required for eradication of organisms for NFLX group were shorter than those for PPA group with significant difference in Shigella spp.
3. No subjective side effect was observed in both groups.
Slightly abnormal laboratory findings were seen in 11 cases of NFLX group and 7 cases of PPA group.
4. On clinical usefulness judged by the docters the ratio of usefulness were 100% in NFLX group and 86.0% in PPA group with significans difference in bacillary dysentery.
From these results, NFLX is considered to be very useful medicine in the treatment of patients with infectious enteritis or carriers.
View full abstract